U.S. Metals and Mining Stock News

NYSE:EQT
NYSE:EQTOil and Gas

EQT Deepens LNG Ties With Commonwealth And Glencore To Shape Future Cash Flows

EQT (NYSE:EQT) agreed to purchase an additional 1 million metric tons of LNG per year from Commonwealth LNG, bringing its total contracted volume to 2 million tons annually. Glencore now has long-term commitments for 3 million tons of LNG per year from Commonwealth LNG. With these contracts, Commonwealth LNG reports that 8 of its planned 9.5 million tons of annual capacity is now under long-term agreements. EQT is a major U.S. natural gas producer, and this latest LNG deal increases its...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Is Perrigo (PRGO) Pricing Reflect Its Recent Rebound And Weak Long Term Returns

Wondering whether Perrigo's current share price makes sense or if the market has mispriced it? This article walks through the key valuation clues that can help you frame that question. The stock has seen a 0.1% move over the last 7 days and a 16.8% return over the past month, set against a much tougher picture with a 21.8% decline year to date and a 52.9% fall over the last year, as well as 65.7% and 68.3% declines over 3 and 5 years respectively. Recent attention on Perrigo has focused less...
NasdaqGS:AUGO
NasdaqGS:AUGOMetals and Mining

Aura Minerals Record Q1 Output Underpins 600,000 GEO Growth Target

Aura Minerals (NasdaqGS:AUGO) reported record preliminary Q1 2026 production results. The company is targeting annual output of more than 600,000 gold equivalent ounces (GEO) in 2026. Recent mine expansions and ramp ups contributed to the new quarterly production milestone. Projects such as Borborema and Almas underground are advancing alongside the multi mine growth plan. Aura Minerals operates a portfolio of gold and copper mines across the Americas, giving the company exposure to both...
NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

ASP Isotopes (ASPI) Revenue Surge Tests Bullish Growth Narratives Against Deepening Losses

ASP Isotopes (ASPI) has just put out its FY 2025 numbers, with Q4 revenue of about US$16.7 million and a Q4 basic EPS loss of US$0.76. Trailing twelve month revenue sits at roughly US$23.8 million against a TTM basic EPS loss of US$2.11. The company has seen quarterly revenue move from around US$1.2 million in Q4 FY 2024 to US$16.7 million in Q4 FY 2025, while trailing twelve month revenue shifted from about US$4.1 million to US$23.8 million over the same window. Investors will now be...
NYSE:BOOT
NYSE:BOOTSpecialty Retail

Boot Barn Holdings (BOOT) Is Up 14.8% After Raised Guidance And Upgrades From Jefferies And BofA

In early April 2026, Boot Barn Holdings reported strong fiscal third-quarter results and raised its fiscal 2026 sales and EPS guidance, while analysts highlighted the potential impact of higher oil-driven production and shipping costs on its margins later this year. The company also drew fresh attention from Wall Street as Jefferies upgraded its rating and Bank of America added Boot Barn to its “Top 10 US Ideas” list, reflecting growing confidence in its store expansion, brand positioning,...
NYSE:U
NYSE:USoftware

Unity’s AI Ads Pivot Puts Vector And Meta Partnership In Focus

Unity Software (NYSE:U) is pivoting its ads business toward AI, positioning the Vector ad platform as its primary growth driver. The company is sunsetting the legacy ironSource Ads Network and is exploring a sale of its Supersonic publishing unit. Management expects Vector to reach a billion dollar annual run rate, with recent trends supporting upgrades to company guidance. Unity Software enters this shift with a share price of $21.62 and a mixed return profile, including a 51.1% decline...
NYSE:STT
NYSE:STTCapital Markets

State Street ETF Push And Governance Debate Create Valuation Talking Point

State Street (NYSE:STT) has filed to launch a Nasdaq 100 Index ETF, entering a segment where Invesco has been a long-standing player. The firm is extending its relationship with Thornburg Investment Management to service new ETF share classes across Thornburg funds. Shareholders have introduced a proposal seeking a policy for an independent board chair at State Street. For investors watching the ETF space, these moves put State Street, a major global custody bank and asset manager, closer...
NasdaqGM:ANL
NasdaqGM:ANLBiotechs

Adlai Nortye (ANL) Loss Narrows To US$18.3 Million Challenging Bearish Cash Burn Narrative

Adlai Nortye (NasdaqGM:ANL) has posted its FY 2025 first half results with total revenue of effectively US$0, a basic EPS loss of US$0.57 and net income loss of US$18.34 million, keeping the story firmly about cash burn and margins rather than top line scale. The company has seen recent periods marked by similarly low reported revenue, with basic EPS losses of US$0.64 and US$1.06 and net income losses of US$24.26 million and US$27.61 million across the two halves of FY 2024. As a result,...
NYSE:ADNT
NYSE:ADNTAuto Components

Is It Too Late To Consider Adient (ADNT) After Its 96.3% One Year Rally?

Investors may be wondering whether Adient is still offering value after its recent run, or if most of the upside is already priced in. The stock closed at US$20.42, with returns of 0.2% over 7 days, a 3.7% decline over 30 days, 7.2% year to date, 96.3% over 1 year, a 47.3% decline over 3 years and a 54.9% decline over 5 years, which presents a mixed picture of risk and reward. Recent headlines around Adient have focused on its position within the auto components sector and how the market is...
NasdaqGS:IMVT
NasdaqGS:IMVTBiotechs

Should Batoclimab’s Phase 3 Miss in Thyroid Eye Disease Require Action From Immunovant (IMVT) Investors?

In April 2026, Immunovant reported that two Phase 3 GO studies of its FcRn inhibitor batoclimab in adults with active, moderate-to-severe thyroid eye disease did not meet the pre-specified primary endpoint of ≥2mm proptosis response at Week 24, though safety findings remained consistent and no new signals emerged. The data suggested stronger proptosis improvements during the initial high-dose period and thyroid hormone normalization in hyperthyroid patients similar to prior Graves’ disease...
NYSE:CNM
NYSE:CNMTrade Distributors

Will Softer Q4 Results and Guidance Miss Change Core & Main's (CNM) Investment Narrative?

Core & Main’s recent Q4 earnings report showed a 6.9% year-on-year revenue decline and slight misses on both quarterly revenue and full-year EBITDA guidance compared with analyst expectations. Despite these softer figures, investor reaction suggests the market may have been braced for weaker results or took confidence from management’s commentary and forward-looking remarks. We’ll now explore how the softer Q4 revenue and guidance miss may reshape Core & Main’s broader investment narrative...
NYSE:GSL
NYSE:GSLShipping

How Strong Q4 Results and Fleet Renewal At Global Ship Lease (GSL) Have Changed Its Investment Story

Earlier this month, Global Ship Lease, Inc. reported strong fourth-quarter 2025 results, highlighting a solid cash position, reduced debt, and ongoing strategic fleet renewal, while Chief Compliance Officer Georgios Giannopoulos sold 7,692 Class A common shares on April 7, 2026. The combination of balance sheet strengthening and active fleet renewal underscores management’s focus on reinforcing both financial resilience and operational efficiency in a shifting containership market. Next,...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

Medline’s First FDA Warning Tests Quality Controls And Growth Story

Medline (NasdaqGS:MDLN) has received an FDA warning letter citing manufacturing deficiencies in its angiographic syringe production. The letter, the first major regulatory challenge since Medline went public, focuses on quality and compliance issues with potential patient safety implications. The FDA action requires Medline to address identified problems and document corrective steps before the matter can be closed. For investors following Medline at a share price of $45.6, this FDA warning...
NYSE:GOLF
NYSE:GOLFLeisure

A Look At Acushnet Holdings (GOLF) Valuation As Media Highlights Its Steady Golf Pure Play Profile

Recent media attention around Acushnet Holdings (GOLF), including commentary describing it as a steadier golf pure play and fresh glimpses into its Titleist manufacturing operations, has prompted investors to reassess what the current share price reflects. See our latest analysis for Acushnet Holdings. Recent attention around Acushnet has come as the share price sits at US$97.79, with a 90 day share price return of 12.05% and a 1 year total shareholder return of 60.28%. This suggests momentum...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty Extends Reach With Space NK Deal And Messi Fragrances

Ulta Beauty (NasdaqGS:ULTA) has completed its acquisition of UK beauty retailer Space NK, expanding its presence outside the US. The company is broadening in store e commerce fulfillment and order management capabilities across its footprint. Ulta is rolling out exclusive US access to Messi Fragrances, including Messi Elixir Parfum Intense, and expanding brands such as Virtue Labs in hair and wellness. Ulta Beauty, a large specialty beauty retailer in the US, is pushing more firmly into...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Is It Time To Reassess Nutanix (NTNX) After Its Sharp Share Price Pullback

Wondering whether Nutanix at around US$34.41 is a bargain or a value trap? This article breaks down what that price could imply for you. The stock has seen sharp swings recently, with a 16.3% decline over the last 7 days, a 10.0% decline over 30 days, a 32.0% decline year to date and a 42.0% decline over the last year, even though 3 year and 5 year returns sit at 34.9% and 25.9% respectively. Recent coverage has focused on Nutanix as a key player in cloud infrastructure software and as a...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

ClearBridge’s New Stake and Earnings Beat Could Be A Game Changer For Ensign Group (ENSG)

In recent months, ClearBridge Investments added The Ensign Group, Inc. to its Small Cap Growth Strategy after the company delivered strong fourth-quarter 2025 earnings with margins and adjusted EPS ahead of forecasts despite slightly softer revenue. This combination of new institutional interest and consistent growth through acquisitions in a still-fragmented skilled nursing market highlights how Ensign’s consolidation model remains central to its business story, even as return on invested...
NYSE:FBIN
NYSE:FBINBuilding

Does Fortune Brands Innovations’ (FBIN) Governance Shift Reframe Its Investment Story More Than Soft EPS Guidance?

In early April 2026, Fortune Brands Innovations, Inc. disclosed disappointing Q4 results with full-year EPS guidance below analyst expectations, while also filing proxy materials urging shareholders to vote against a proposal to require annual election of all directors at the upcoming May 5, 2026 annual meeting. An interesting twist is that, even as the company encourages investors to reject a shareholder declassification proposal, it has already obtained approval to amend its certificate...
NYSE:MSM
NYSE:MSMTrade Distributors

MSC Industrial Direct (MSM) Is Up 5.7% After EPS Gains Highlight Improving Profitability – What's Changed

In the past quarter ended February 28, 2026, MSC Industrial Direct reported second-quarter sales of US$917.77 million and net income of US$42.48 million, alongside six-month sales of US$1.88 billion and net income of US$94.29 million, all higher than a year earlier. The company’s higher basic and diluted earnings per share from continuing operations for both the quarter and six-month period highlight a period of improving profitability that may influence how investors assess its longer-term...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

A Look At Performance Food Group (PFGC) Valuation After Weaker Quarter And Muted Sales Growth

Performance Food Group (PFGC) is in focus after weaker than expected quarterly figures and muted sales volume growth raised fresh questions about demand, profitability, and the recent stock price reaction. See our latest analysis for Performance Food Group. The recent quarterly miss and softer volume growth came after a period of mixed trading. A 7 day share price return of 5.94% contrasts with a 90 day share price return decline of 2.10%, while the 1 year total shareholder return of 17.91%...
NYSE:WTTR
NYSE:WTTREnergy Services

What Select Water Solutions (WTTR)'s New Lithium Extraction Partnership Means For Shareholders

LibertyStream Infrastructure Partners has already launched its Direct Lithium Extraction Unit and Lithium Carbonate Refining Facility at Select Water Solutions’ site, securing a pre-sale for its first tonne of lithium carbonate scheduled for delivery in June 2026 and creating a new use for Select’s existing water assets. This development introduces lithium processing as an additional service layered onto Select’s water infrastructure, opening up potential applications beyond traditional...
NYSE:HE
NYSE:HEElectric Utilities

Did HE’s Maui Settlement Plan and Advisor Shift Just Redefine Hawaiian Electric’s (HE) Risk Narrative?

Hawaiian Electric Industries has begun paying wildfire-related settlements, authorizing the first US$479 million installment of a US$1.92 billion, four-year package to resolve all tort claims from the 2023 Maui events and has retained former CFO Scott T. DeGhetto as a consultant on financing and corporate projects after his April 1, 2026 departure. This combination of clarified long-term legal obligations and continued access to DeGhetto’s financing expertise could influence how investors...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Assessing Vericel (VCEL) Valuation After BARDA Awards Up To US$197 Million NexoBrid Contract

BARDA Contract Puts NexoBrid Partnership in Focus for Vericel (VCEL) Vericel (VCEL), the exclusive distributor of NexoBrid in North America, is back on investor radar after a ten-year BARDA contract valued at up to US$197 million, tied to NexoBrid procurement and development. See our latest analysis for Vericel. The BARDA news lands after a mixed run for Vericel, with a 30 day share price return of 2.49% contrasting with a 90 day share price return decline of 12.6% and a 1 year total...
NYSE:JXN
NYSE:JXNDiversified Financial

Assessing Jackson Financial (JXN) Valuation After Leadership Changes At PPM America And Jackson National

Jackson Financial (JXN) is in focus after the company reshaped its leadership by naming Christopher A. Raub as President and CEO of asset manager PPM America and adjusting roles at Jackson National Life Insurance Company. See our latest analysis for Jackson Financial. Recent leadership changes come as Jackson Financial’s share price has eased in the short term, with a 30 day share price return showing a 5.21% decline and a 90 day share price return showing a 13.41% decline. At the same time,...